Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice

Journal of Virology

Volumn 76, Issue 23, 2002, Pages 12149-12161

  Luker, Gary D ^a   Bardill, J Patrick ^a   Prior, Julie L ^a   Pica, Christina M ^a   Piwnica Worms, David ^a   Leib, David A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VALACICLOVIR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; FEMALE; HERPES SIMPLEX VIRUS 1; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS TITRATION; VIRUS TRANSMISSION;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; FEMALE; GENES, REPORTER; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; KERATITIS, HERPETIC; LUCIFERASES; LUMINESCENT MEASUREMENTS; MICE; ORGAN SPECIFICITY; TIME FACTORS; VALINE;

EID: 0036888884     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.23.12149-12161.2002     Document Type: Article

References (35)

1. Benaron, D., P. Contag, and C. Contag. 1997. Imaging brain structure and function, infection and gene expression in the body using light. Philos. Trans. R. Soc. Lond. B Biol. Sci. 352:755-761.
2. Bhaumik, S., and S. Gambhir. 2001. Optical imaging of Renilla luciferase reporter gene expression in living mice. Proc. Natl. Acad. Sci. USA 99:377-392.
3. Blyth, W., D. Harbour, and T. Hill. 1984. Pathogenesis of zosteriform spread of herpes simplex virus in the mouse. J. Gen. Virol. 65:1477-1486.
4. Coen, D., M. Kosz-Vnenchak, J. Jacobson, D. Leib, C. Bogard, P. Schaffer, K. Tyler, and D. Knipe. 1989. Thymidine kinase negative herpesvirus mutants establish latency in mouse trigeminal ganglia, but do not reactivate. Proc. Natl. Acad. Sci. USA 86:4736-4740.
5. Contag, C., P. Contag, J. Mullins, S. Spilman, D. Stevenson, and D. Benaron. 1995. Photonic detection of bacterial pathogens in living hosts. Mol. Microbiol. 18:593-603.
6. Contag, C., S. Spilman, P. Contag, M. Oshiro, B. Eames, P. Dennery, D. Stevenson, and D. Benaron. 1997. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem. Photobiol. 66:523-531.
7. Costa, G., M. Sandora, A. Nakajima, E. Nguyen, C. Taylor-Edwards, A. Slavin, C. Contag, C. Fathman, and J. Benson. 2001. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J. Immunol. 167:2379-2387.
8. Crute, J., C. Grygon, K. Hargrave, B. Simoneau, A. Faucher, G. Bolger, P. Kibler, M. Liuzzi, and M. Cordingley. 2002. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease. Nat. Med. 8:386-391.
9. Dyson, H., C. Shimeld, T. Hill, W. Blyth, and D. Easty. 1987. Spread of herpes simplex virus within ocular nerves of the mouse: Demonstration of viral antigen in whole mounts of eye tissue. J. Gen. Virol. 68:2989-2995.
10. Feldman, L., A. Ellison, C. Voytek, L. Yang, P. Krause, and T. Margolis. 2002. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc. Natl. Acad. Sci. USA 99:978-983.
11. Francis, K., D. Joh, C. Bellinger-Kawahara, M. Hawkinson, T. Purchio, and P. Contag. 2000. Monitoring bioluminescent Staphylococcus aureus infections in live mice using a novel luxABCDE construct. Infect. Immun. 68: 3594-3600.
12. Francis, K., J. Yu, C. Bellinger-Kawahara, D. Joh, M. Hawkinson, G. Xiao, T. Purchio, M. Cararon, M. Lipsitch, and P. Contag. 2001. Visualizing pneumococcal infections in the lungs of live mice using bioluminescent Streptococcus pneumonia transformed with a novel gram-positive lux transposon. Infect. Immun. 69:3350-3358.
13. Glantz, S. A. 1987. Primer of Biostatistics, 2nd Ed. McGraw-Hill, Inc., New York, N.Y.
14. Kleymann, G., R. Fisher, U. Betz, M. Hendrix, W. Bender, U. Schneider, G. Handke, P. Eckenberg, G. Hewlett, V. Pevzner, J. Baumeister, O. Weber, K. Henninger, J. Keldenich, A. Jensen, J. Kolb, U. Bach, A. Popp, J. Maben, I. Frappa, D. Haebich, O. Lockhoff, and H. Rubsamen-Waigman. 2002. New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease. Nat. Med. 8:392-398.
15. Labetoulle, M., P. Kucera, G. Ugolini, F. Lafay, E. Frau, H. Offret, and A. Flamand. 2000. Neuronal propagation of HSV1 from the oral mucosa to the eye. Investig. Ophthalmol. Vis. Sci. 41:2600-2606.
16. 134.5 transcripts and latency-associated transcripts. J. Virol. 72:4250-4264.
17. Leib, D., D. Coen, C. Bogard, K. Hicks, D. Yager, D. Knipe, K. Tyler, and P. Schaffer. 1989. Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J. Virol. 63:759-768.
18. Leib, D., T. Harrison, K. Laslo, M. Machalak, N. Moorman, and H. Virgin. 1999. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189:663-672.
19. Leib, D., M. Machalek, B. Williams, R. Silverman, and H. Virgin. 2000. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc. Natl. Acad. Sci. USA 97:6097-6101.
20. Lipshutz, G., C. Gruber, Y. Cao, J. Hardy, C. Contag, and K. Gaensler. 2001. In utero delivery of adeno-associated viral vectors: Intraperitoneal gene transfer produces long-term expression. Mol. Ther. 3:284-292.
21. Lorenz, W., M. Ro, M. Longiaru, and M. Cormier. 1991. Isolation and expression of a cDNA encoding Renilla reniformis luciferase. Proc. Natl. Acad. Sci. USA 88:4438-4442.
22. O'Connell-Rodwell, C., S. Burns, M. Bachmann, and C. Contag. 2002. Bioluminescent indicators for in vivo measurements of gene expression. Trends Biotechnol. 20:S19-S23.
23. Preston, C. 2000. Repression of viral transcription during herpes simplex virus latency. J. Gen. Virol. 81:1-19.
24. Pyles, R., N. Sawtell, and R. Thompson. 1992. Herpes simplex virus type 1 dUTPase mutants are attenuated for neurovirulence, neuroinvasiveness, and reactivation from latency. J. Virol. 66:6706-6713.
25. Rader, K., C. Ackland-Berglund, J. Miller, J. Pepose, and D. Leib. 1993. In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts. J. Gen. Virol. 74: 1859-1869.
26. Sadikot, R., E. Jansen, T. Blackwell, O. Zoia, F. Yull, J. Christman, and T. Blackwell. 2001. High-dose dexamethasone accentuates nuclear factor-κβ activation in endotoxin-treated mice. Am. J. Respir. Crit. Care Med. 164: 873-878.
27. Summers, B., and D. Leib. 2002. Herpes simplex virus type 1 origins of DNA replication play no role in the regulation of flanking promoters. J. Virol. 76:7020-7029.
28. Summers, B., T. Margolis, and D. Leib. 2001. Herpes simplex virus type 1 corneal infection results in periocular disease by zosteriform spread. J. Virol. 75:5069-5075.
29. Sweeney, T., V. Mailander, A. Tucker, A. Olomu, W. Zhang, Y. Cao, R. Negrin, and C. Contag. 1999. Visualizing the kinetics of tumor-cell clearance in living animals. Proc. Natl. Acad. Sci. USA 96:12044-12046.
30. Taus, N., and W. Mitchell. 2001. The transgenic ICP4 promoter is activated in schwann cells in trigeminal ganglia of mice latently infected with herpes simplex virus type 1. J. Virol. 75:10401-10408.
31. Thackray, A., and H. Field. 2000. The effects of antiviral therapy on the distribution of herpes simplex virus type 1 to ganglionic neurons and its consequences during, immediately following and several months after treatment. J. Gen. Virol. 81:2585-2596.
32. Tran, R., P. Lieu, S. Aguilar, E. Wagner, and D. Bloom. 2002. Altering the expression kinetics of VP5 results in altered virulence and pathogenesis of herpes simplex virus type 1 in mice. J. Virol. 76:2199-2205.
33. Whitley, R. 1996. Herpes simplex viruses, p. 2297-2342. In B. Fields, D. Knipe, P. M. Howley, et al. (ed.), Fields Virology, 3rd Ed. Lippincott-Raven Publishers, Philadelphia, Pa.
34. Wu, J., G. Sundaresan, M. Iyer, and S. Gambhir. 2001. Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice. Mol. Ther. 4:297-306.
35. Yamada, Y., H. Kimura, T. Morishima, T. Daikoku, K. Maeno, and Y. Nishiyama. 1991. The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice. J. Infect. Dis. 164:1091-1097.